About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Coalition of University TTOs File Amicus Brief in Lighting Ballast Control LLC v. Philips Electronics North America Corp. | Main | Myriad Genetics Files Suit Against Ambry Genetics for Genetic Diagnostic Testing of BRCA Genes »

July 09, 2013

BIO IP & Diagnostics Symposium

Biotechnology Industry Organization (BIO)The Biotechnology Industry Organization (BIO) will be holding an IP & Diagnostics Symposium from 8:00 am to 2:45 pm on July 22, 2013 at the Hilton Alexandria Old Town Hotel in Alexandria, VA.  The Symposium will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors.  The program will review IP issues for diagnostics and companion diagnostics, and explore potential regulatory dimensions.  In hosting the event, BIO aims to inform industry and government alike on how to move the science forward in the current climate.  The Symposium will offer the following presentations and sessions:

• Keynote breakfast -- Jeffrey N. Peterson, Chief Executive Officer, Target Discovery, Inc.

• Session 1 -- Obtaining Patent Protection -- Patent Docs author Donald Zuhn of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel including Mary Till, Legal Advisor, Office of Patent Legal Administration, U.S. Patent & Trademark Office; Duane Marks, Patent Counsel, Roche Diagnostics Operations, Inc.; and Patent Docs author Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP

• Session 2 -- Regulatory & Reimbursement -- Jennifer L. Fox of Brinks Hofer Gilson & Lione will moderate a panel including Sheila D. Walcoff, Founding Principal, Goldbug Strategies LLC

• Session 3 (Working Luncheon) -- Business Development & Strategic Deals -- Eric Steffe of Sterne Kessler Goldstein & Fox LLP will moderate a panel including Tim Shea of Sterne Kessler Goldstein & Fox LLP; Pia Maria Gargiulo, Managing Director, Companion Diagnostics, Precision for Medicine; Mollie Roth of PGx Consulting; and Zoran Zdraveski, Senior Director of Intellectual Property, Epizyme, Inc.

An agenda for the Symposium, including a list of speakers, moderators, and panelists can be obtained here.

Although there is no registration fee for the Symposium, space is limited and attendees must register for the program.  A registration form can be obtained here.  Additional information regarding the Symposium can be found on BIO's Patently Biotech blog.

Posted at 11:25 PM in Conferences & CLE's |

Comments

The comments to this entry are closed.

November 2024

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Categories

Archives

More...